BEAM — Beam Therapeutics Inc
In 2026 Q2, 4 of the 140 tracked hedge funds reported a position in Beam Therapeutics Inc (BEAM), worth $23.15M combined. Over the quarter 2 opened or added, 3 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $15.27M | 0.02% | -13.4% |
| Duquesne | $5.27M | 0.12% | NEW |
| Peregrine | $2.40M | 1.00% | -73.1% |
| Chapin Davis | $205.92K | 0.04% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.